Sign In
Buy ADI
$437.67
+14.47 (+3.42%)
At Close: Jun 03, 2026
Dividend Aristocrats Of The Future - Part 1
09:49am, Tuesday, 22'nd Oct 2024
A list of 10 companies well on their way to reaching dividend aristocrat status. These companies offer investors a variety of starting yields and span multiple sectors. The majority of these companies
Semiconductor Earnings Are Coming. 1 Stock to Buy, According to an Analyst.
01:01pm, Wednesday, 16'th Oct 2024
Citi is keeping an eye on weak demand in the PC and auto markets.
Analog Devices (ADI) Falls More Steeply Than Broader Market: What Investors Need to Know
07:20pm, Thursday, 10'th Oct 2024
In the most recent trading session, Analog Devices (ADI) closed at $230.70, indicating a -1.09% shift from the previous trading day.
Can ADI's New Developer-Centric Offerings Push the Stock Higher?
11:37am, Wednesday, 09'th Oct 2024
Analog Devices' new product offerings can be beneficial for the stock. However, stretched valuation keeps investors on the sidelines.
Citi Increases Optimism on Semiconductor Sector After Strong August Sales
09:30am, Tuesday, 08'th Oct 2024
Citi has expressed increased optimism towards the semiconductor industry following stronger-than-expected sales data for August. Analog Devices (ADI, Financial) remains Citi's top pick in the sector.
CodeFusion Studio™ and ADI's new Developer Portal are inaugural components of a new suite of developer-centric offerings, which unite cross-device, cross-market hardware, software and services Also
Analog Devices (ADI) Rises Yet Lags Behind Market: Some Facts Worth Knowing
07:05pm, Friday, 04'th Oct 2024
Analog Devices (ADI) concluded the recent trading session at $228.23, signifying a +0.74% move from its prior day's close.
Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases
07:00am, Monday, 30'th Sep 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Analog Devices (ADI) Registers a Bigger Fall Than the Market: Important Facts to Note
07:06pm, Friday, 27'th Sep 2024
In the most recent trading session, Analog Devices (ADI) closed at $232.05, indicating a -0.18% shift from the previous trading day.
Analog Devices (ADI) Declines More Than Market: Some Information for Investors
07:20pm, Wednesday, 25'th Sep 2024
The latest trading day saw Analog Devices (ADI) settling at $226.64, representing a -0.3% change from its previous close.
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
09:50am, Monday, 23'rd Sep 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Is Analog Devices (ADI) Up 5.2% Since Last Earnings Report?
12:31pm, Friday, 20'th Sep 2024
Analog Devices (ADI) reported earnings 30 days ago. What's next for the stock?
ADI Partners With India's Tata Group: How Should You Play the Stock?
01:20pm, Thursday, 19'th Sep 2024
Analog Devices' collaboration with Tata Group to explore semiconductor opportunities in India bodes well for the stock.
ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
07:00am, Thursday, 19'th Sep 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Analog Devices, Tata Group in talks to make semiconductors in India
01:25am, Thursday, 19'th Sep 2024
Analog Devices (ADI) and Indian salt-to-aviation conglomerate Tata Group have signed a pact to explore making semiconductor products in India, the U.S. chipmaker said on Wednesday.
